Due to the concern about the growing prevalence of unapproved GLP-1s on the market, the FDA issued warning letters to the following companies in December: The FDA warned the companies about potential violations of the Federal Food, Drug, and Cosmetic Act (FD&C Act), even with the companies claiming some of their GLP-1 products were currently for research purposes only
Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry
Here, by consolidating data on differential methylation in the Bangladeshi women who had grown in Bangladesh (more pathogenic environment) or the UK, together with differences in ovarian gene expression in a mouse model of prepubertal immune challenge, we identified the downregulation in SRD5A1
Altered processing of sensory stimuli in patients with migraine
You just alluded to how the administration, both Trump and Biden administration, have championed the for the hospital transparency
Supplied as a high-purity, lyophilized powder, it is intended strictly for laboratory research use